Thirty Madison Platform
Virtual-first specialized healthcare platform
Company profile
Company profile
Thirty Madison is a healthcare technology company that operates a portfolio of specialized virtual care brands focused on chronic condition management. The company takes a condition-specific approach to telehealth, building dedicated platforms for individual chronic conditions rather than offering generalized virtual care. Through its family of brands, Thirty Madison provides end-to-end care including online consultations, diagnosis, personalized treatment plans, prescription medications, and ongoing support. The company's model combines licensed healthcare providers, proprietary technology platforms, and direct-to-patient medication delivery to create comprehensive virtual care experiences. By focusing on specific chronic conditions, Thirty Madison aims to develop deep clinical expertise and tailored patient experiences for each condition it serves. The virtual-first approach enables the company to reach patients across geographic boundaries and provide convenient, accessible care for conditions that require ongoing management and support.
Company description Thirty Madison official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Virtual-first specialized healthcare platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Applied clinical informatics · May 1, 2024
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Apr 1, 2023
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Apr 1, 2023
Digital health platforms expand access and improve care for male androgenetic alopecia.International journal of dermatology · Feb 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Thirty Madison's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.